Experience of brucellosis treatment with ciprofloxacin

Antibiotiki i Khimioterapiya

Volumn 47, Issue 10, 2002, Pages 3-7

  Duisenova, A K ^a   Kurmanova, K B ^a   Kurmanova, G M ^a  

^a Sci Ctr of Hyg and Epidemiology   (Kazakhstan)

Author keywords

Brucellosis; Ciprofloxacin; Immunity

Indexed keywords

CIPROFLOXACIN; DOXYCYCLINE; RIFAMPICIN;

ACUTE DISEASE; ADULT; ANTIBODY PRODUCTION; ARTICLE; BRUCELLA MELITENSIS; BRUCELLOSIS; CHRONIC DISEASE; COMPARATIVE STUDY; DRUG COMBINATION; DRUG EFFECT; HOSPITALIZATION; HUMAN; IMMUNOLOGY; ISOLATION AND PURIFICATION; MIDDLE AGED; TREATMENT OUTCOME;

ACUTE DISEASE; ADULT; ANTIBODY FORMATION; BRUCELLA MELITENSIS; BRUCELLOSIS; CHRONIC DISEASE; CIPROFLOXACIN; DOXYCYCLINE; DRUG THERAPY, COMBINATION; HUMANS; MIDDLE AGED; RIFAMPIN; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 11244330375     PISSN: 02352990     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (5)

1. Carillo C., Gotuzzo E., Adachi J., Talmos J. In vitro antimicrobal susceptibility of Brucella melitensis strains isolated in an endemic area (Lima, Peru). Rev Espanola Quimiotrapia 1993; 6: 4: 309-313.